García GMA, Ricardez GJA, Blas AR, Sandoval GJP, Gutiérrez RFJ, Vicencio TA

Language: Spanish
References: 9
Page: 217-220
PDF size: 273.36 Kb.

Text Extraction

No abstract

REFERENCES

1. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile associated diarrhea and colitis. Am J Gastroenterol 1997; 92: 739-750.

2. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000; 342(s6): 390-397.

3. Beck PG. A new look at toxic megacolon: an update and review of incidence etiology, pathogenesis, and management. Am J Gastroenterol 2003; 98: 2363-2371.

4. Aslam S, Musher DM. An update of diagnosis, treatment and prevention of Clostridium difficile. Gastroenterol Clin N Am 2006; 35: 315-335.

5. Surawicz CM. Clostridium difficile disease. Gastroenterology 1998; 6(1): 60-65.

6. Hurley BW, Nguyen CC. The spectrum of pseudomembranous enterocolitis and antibiotic- associated diarrhea. Arch Intern Med 2002; 162: 2177-2184.

7. Jalan KN, Circus W, Cord WI et al. An experence with ulcerative colitis: toxic dilatation in 55 cases. Gastroenterology 1969; 57: 68-82.

8. Klipfel A, Schin M, Fahoum B, Wise L. Lipfel. Acute abdomen and Clostridium difficile colitis: still a lethal combination. Dig Surg 2000; 17: 160-163.

9. Grundfest-Broniatowski S, Quader M, Alexander F et al. Clostridium difficile colitis in the critically ill. Dis Colon Rectum 1996; 39: 619-623.